In the last few years, different surveillances have been published in Africa, especially in northern countries, regarding antimicrobial resistance among husbandry animals. Information is still scarce, but the available data show a worrying picture. Although the highest resistance rates have been described against tetracycline, penicillins and sulphonamides, prevalence of plasmidmediated quinolone resistance genes and extended spectrum b-lactamase (ESBL) are being increasingly reported. Among ESBLs, the CTX-M-1 group was dominant in most African surveys. Within this group, CTX-M-15 was the main variant both in animals and humans, except in Tunisia where CTX-M-1 was more frequently detected among Escherichia coli from poultry. Certain bla CTX-M-15 -harbouring clones (ST131/B2 or ST405/D) are mainly identified in humans, but they have also been reported in livestock species from Tanzania, Nigeria or Tunisia. Moreover, several reports suggest an inter-host circulation of specific plasmids (e.g. bla CTX-M-1 -carrying IncI1/ST3 in Tunisia, IncY-and Incuntypeable replicons co-harbouring qnrS1 and bla CTX-M-15 in Tanzania and the worldwide distributed bla CTX-M-15 -carrying IncF-type plasmids). International trade of poultry meat seems to have contributed to the spread of other ESBL variants, such as CTX-M-14, and clones. Furthermore, first descriptions of OXA-48-and OXA-181-producing E. coli have been recently documented in cattle from Egypt, and the emergent plasmid-mediated colistin resistance mcr-1 gene has been also identified in chickens from Algeria, Tunisia and South Africa. These data reflect the urgent need of a larger regulation in the use of veterinary drugs and the implementation of surveillance programmes in order to decelerate the advance of antimicrobial resistance in this continent.
Introduction
The rapid increase in the rate of antimicrobial-resistant bacteria (AMR) reinforced by the opposite tendency in the development of new active drugs is currently one of the most serious public health threats, as recognized by the World Health Organization (http://www.who.int/dru gresistance/documents/surveillancereport/en). Resistance trends in Gram-negative bacilli are particularly alarming due to limited antibiotic options to treat infections caused by some organisms (especially Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter) that are becoming resistant to nearly all available antimicrobials, including carbapenems.
This global emergence of multidrug-resistant bacteria has been attributed to the overuse and misuse of antibiotics, not only in human medicine but also in farming and veterinary sectors. In fact, the worldwide use of antibiotics for animal health and production purposes exceeds the use in humans, and most of the drugs designed exclusively for veterinary use are closely related or belong to the same antimicrobial classes of those indicated for humans (Aarestrup et al. 2008; Cantas et al. 2013) . In Europe, according to the data Letters in Applied Microbiology 64, 318--334 © 2017 The Society for Applied Microbiology from 10 countries, the amount of veterinary antimicrobial agents sold in 2007 varied from 18 to 188 mg kg À1 biomass of food-producing animals (FPA), and were globally predominant the sales of sulphonamides and trimethoprim (alone or in combination), tetracyclines and b-lactams (Grave et al. 2010) . In Japan, the amounts varied between 132 mg kg À1 and 153 mg kg À1 from 2005 to 2010 (Hosoi et al. 2013 ). In general, in developed countries, the use of antibiotics is strictly controlled and documented, but this is not the case in developing countries of the African continent where veterinary antimicrobials are often readily sold in shops and markets without prescriptions (Mainda et al. 2015) . Unfortunately, as expected, it has been demonstrated that the use of antimicrobial agents in husbandry is directly related to the incidence of resistant bacteria in FPA (Baron et al. 2014; Chantziaras et al. 2014) . Selection of these antimicrobial-resistant (AMR) bacteria that asymptomatically colonize the gut of animals might play an epidemiological role in the spread of resistance between FPA and humans, either through direct contact or consumption of contaminated food. Inter-host transmission is more likely to happen in rural areas of developing countries with mainly subsistence-based agricultural economies, such as some regions in Africa, where people frequently live in close contact with livestock animals.
Because of the growing problem of antibiotic resistance worldwide, the number of studies focusing on the epidemiology of AMR bacteria, with special attention to extended spectrum b-lactamase (ESBL), plasmidmediated AmpC b-lactamase (pAmpC) and carbapenemase production in Enterobacteriaceae, has increased over the last few years. The majority of these reports have been carried out in Escherichia coli, generally considered a useful indicator of antimicrobial resistance due to its medical importance and its presence in a wide range of hosts. This allows comparisons of prevalence between different populations and the evaluation of antimicrobial resistance transmission from animals to humans and vice versa (Van den Bogaard and Stobberingh 2000) . Despite limited resources, the incidence of AMR Enterobacteriaceae in Africa, and more specifically, ESBL producers has also been studied at the local level in different countries. There are also some reviews about the general situation in the whole continent, but most of them are concentrated in human clinical and community settings (Storberg 2014; Sangare et al. 2015; Sekyere et al. 2016) . In the present review, we aim to describe the situation of AMR E. coli in FPA and foods of animal origin in Africa, with particular focus on ESBL/pAmpC-producing isolates.
Literature search strategy and data extraction
A literature search was conducted in PubMed database for original articles reporting data on AMR E. coli from African countries. The review was limited to studies published in English between January 2007 and November 2016. We used combinations of relevant keywords, such as (i) 'E. coli'; (ii) 'antimicrobial resistance', 'antibiotic resistance', 'antimicrobial usage', 'antibiotic usage', 'ESBL', 'extended spectrum b-lactamases', 'carbapenemases'; (iii) general ('livestock animals', 'farm animals', 'husbandry', 'food-producing animals') and specific animal descriptors (e.g. 'poultry', 'chickens', 'swine', 'pigs', 'cattle'); (iv) 'Africa' and the names of each African nation. References of articles were reviewed to identify any other relevant publication and, additionally, an online search was carried out to consult documents from international organizations (e.g. WHO, OIE).
The first author, country, year of sampling, sample type, sample size, animal health status, prevalence and distribution of antimicrobial resistance, resistance genes/ mechanisms and molecular typing data were extracted from all the included studies.
Antimicrobial usage in livestock and resistance patterns in E. coli Antimicrobial agents can be used in animal husbandry not only for the treatment and prevention of infectious diseases but also, at low and subtherapeutic doses, as growth promoters. Although their use allows to protect animal health and welfare with lower incidence of disease and also contributes to food safety, there is evidence to suggest that are leading to the spread of antimicrobial resistance (Chantziaras et al. 2014 ) with important public health implications. In this sense, on the basis of precautionary principles, European Union banned in 2006 the use of all growth-promoting antibiotics (Hao et al. 2014) . Unfortunately, this preventive measure has not been taken all over the world, and antimicrobial agents are still used for this purpose in many developed and developing countries.
In general, the use and control of antimicrobials in the developing world, including countries of the African continent, remains largely unregulated (Maron et al. 2013) . According to the World Organisation for Animal Health (http://www.oie.int/), many countries-mainly developing and emerging ones-do not yet have relevant legislation concerning appropriate conditions for the use of veterinary products, including antimicrobials. In some cases, legislation is totally nonexistent, and where it does exist it is very often not properly applied. Some African studies focused on the antimicrobial usage in livestock indicate Letters in Applied Microbiology 64, 318--334 © 2017 The Society for Applied Microbiology that there is an irrational use due to the unregulated access and even administration of veterinary drugs (Eager et al. 2012; Adesokan et al. 2015; Mainda et al. 2015) . Even though in many African countries it is illegal for any person who is not a registered veterinarian to administer antibiotics, there are no strict control measures, and often farmers purchase and administer a drug without veterinary prescription and supervision (Adesokan et al. 2015; Mainda et al. 2015) . Unfortunately, the use of antimicrobials in animals by untrained personnel is not confined to developing and emerging countries (http:// www.oie.int/).
Furthermore, it is also important to note that the first study estimating the global trends in antimicrobial use in livestock production found that the global consumption of antimicrobials will increase in the future and this rise is likely to be driven by the growth in consumer demand for livestock products in middle-income countries and a shift to large-scale farms where antimicrobials are used routinely (Van Boeckel et al. 2015) .
The data of different surveys conducted in Nigeria (Adesokan et al. 2012) , Zambia (Mainda et al. 2015) and South Africa (Eager et al. 2012) about the sales of antimicrobials for farm animals indicate that, even considering variations between countries or animal species (mammals or poultry), tetracyclines and b-lactams (mainly penicillins) are among the first four leading antibiotics commonly employed in livestock animal production. Sulphonamides and macrolides are also frequently consumed antimicrobials, this last group (with reference specifically to tylosin) has been reported as the most extensively sold in South Africa for treatment and prevention of veterinary diseases and also, at subtherapeutic levels, as a registered growth promoter (Eager et al. 2012) . Equally worrisome is the veterinary overuse of fluoroquinolones (critically important in human medicine) in some African regions, as it has been documented in a survey conducted in south-western Nigeria (Adesokan et al. 2015) .
In a study carried out in Ghana, 395 commercial livestock keepers who practice intensive or extensive farming were interviewed about their antibiotic usage practice (Donkor et al. 2012) . Most of the farmers used veterinary drugs mainly for disease prevention, followed by the dual purpose of prevention and treatment, only treatment and, less often, also for growth promotion. Of course, it is important to mention that the data collected from livestock keepers were self-reported, which may pose certain limitations. Another significant aspect to consider is the antibiotic administration bias commonly employed in livestock production, which is obviously different from those used in human medicine. A survey conducted in South Africa showed that in-feed dosage forms constituted almost 70% of the total of antimicrobial dosages sold in this country (Eager et al. 2012 ). This practice favours that an entire group of animals be medicated at the same time contrary to the individual treatment given to patients.
Moreover, recent data from Nigeria show a significant increasing trend in the veterinary antimicrobial consumption, which is not proportional to the annual livestock rate in the area (Adesokan et al. 2015) . Regarding the type of livestock species, some studies suggest a relatively higher rate of antimicrobial usage among chickens, which is expressed in the more elevated percentage of resistant isolates detected among this particular animal population (Ben Sallem et al. 2012b; Donkor et al. 2012; Adenipekum et al. 2015) . A European report based on data gathered from seven countries also showed higher resistance rates in poultry (Chantziaras et al. 2014 ). This may be explained, in part, by the fact that antibiotic usage is even higher in intensive farming, more common in poultry, where animals are reared in close proximity.
In general, although resistance percentages vary significantly among regions and studied animal populations, the highest rates have been reported for tetracycline (10Á6-95%), ampicillin (6Á02-95Á7%) and trimethoprim/sulfamethoxazole (4Á49-80%) (Wesonga et al. 2010; Donkor et al. 2012; Adelowo et al. 2014; Adenipekum et al. 2015; Mainda et al. 2015; Rugumisa et al. 2016) . African studies on foods of animal origin (retail chicken or turkey meat, beef and pork carcasses) also report that resistance levels to these antimicrobials are among the most relevant ones (Soufi et al. 2009; Odwar et al. 2014; Luanda et al. 2016; Mrutu et al. 2016 ). This is not surprising because these drugs have been in use for the longest time both in human and veterinary medicine (Tadesse et al. 2012) . Their combined resistance, often due to the co-location of different determinants in the same mobile genetic elements (plasmids, transposons and/or integrons), has contributed to the selection of multidrug-resistant (MDR) isolates worldwide (Wesonga et al. 2010; Tadesse et al. 2012; Adenipekum et al. 2015) . The presence and diversity of integrons in E. coli from poultry, poultry meat and cattle have been studied in various reports from Africa (Soufi et al. 2009; Ben Slama et al. 2010; Inwezerua et al. 2014; Maamar et al. 2016 ) and showed high rates of prevalence of class 1 and class 2 integrons (60%) containing, as commonly occur, trimethoprim (dfr) and streptomycin (aad) resistance encoding genes.
Regarding other antimicrobial classes, such as quinolones and cephalosporins, the picture is even more worrying due to their vital importance in the treatment of a wide variety of infections in humans and the fact that resistance against them leaves few therapy options. Livestock as reservoirs of ESBL-producer bacteria will be Letters in Applied Microbiology 64, 318--334 © 2017 The Society for Applied Microbiology discussed in the following sections because of its relevance in terms of emerging resistance properties and the substantial literature available. Some studies performed in Tunisia and Nigeria reported unexpected high prevalence of resistance to quinolones among cattle (61Á2%) (Grami et al. 2014 ) and poultry (42-55%) (Fortini et al. 2011; Adelowo et al. 2014) , because this antimicrobial class was introduced later than others in livestock and is relatively expensive. Resistance to quinolones and fluoroquinolones is mainly driven by chromosomal mutations at the quinolone resistance determining region (QRDR) of DNA gyrase and topoisomerase IV. However, plasmid-mediated quinolones resistance mechanisms (PMQR) (such as, qnr proteins, aac(6)-Ib-cr aminoglycoside acetyltransferase and efflux pump proteins like QepA or OqxAB) have been progressively detected and contribute to an increase in the MIC of quinolones and fluoroquinolones. In Nigeria, a country where previous studies had reported a high prevalence of PMQR genes in clinical samples from humans (Ogbolu et al. 2011) , an important study was carried out in poultry and pigs to characterize PMQR determinants and associated plasmids and clones (Fortini et al. 2011 ). The resulting data, which identified four PMQR gene variants (qnrB10, qnrB19, qnrS1 and qepA1) located on five different plasmid types (IncHI2, ColE, IncI1, IncN and IncX2), suggested that FPA can act as reservoirs of PMQR determinants. In particular, this work demonstrated the wide circulation in the area of qnrS1 gene harboured mainly in IncX2, IncN and IncI1 plasmids, qnrB19 in small ColE-like plasmids and qepA1 in plasmids of HI2 incompatibility group. Moreover, the same IncI1-ST12 plasmid harbouring qnrS1 was detected in commensal E. coli isolates from poultry in the mentioned study and in Salmonella strains in other independent work carried out previously in Nigeria (Fashae et al. 2010) . Regarding other remarkable aspect of this study, all the strains carried the bla TEM-1 gene and one was positive for CTX-M-15 b-lactamase. In fact, association between qnr or aac(6)Ib-cr and bla genes has been frequently reported worldwide, including some African countries (Mnif et al. 2012; Ben Sallem et al. 2014; Inwezerua et al. 2014; Kilani et al. 2015; Belmahdi et al. 2016; Ojo et al. 2016; Seni et al. 2016) .
It is also important to highlight the detection of E. coli isolates carrying the emerging plasmid-mediated colistin resistance gene mcr-1 in chickens from Algeria (Olaitan et al. 2016) , South Africa (Perreten et al. 2016 ) and three poultry farms from Tunisia (Grami et al. 2016) . Tunisian isolates, collected from chickens imported from France, were further characterized and demonstrated to carry bla CTX-M-1 and mcr-1 genes co-localized on the same IncHI2-type plasmid. This plasmid was also found in veal calves in France and food samples in Portugal (Tse and Yuen 2016) , highlighting the impact of food animal trade on the dissemination of mcr-1-mediated colistin resistance. This polymyxin is currently considered a last-resort antibiotic for the treatment of highly resistant pathogenic bacteria in human medicine. However, it has been also extensively used in animal production worldwide (Rhouma et al. 2016) leading to a potential selection of resistant strains which reflects, once again, the urgent need of a better control in the global market of veterinary drugs.
Regarding surveillances performed on specific pathogenic strains, such as Shiga-toxin producing E. coli O157, a high prevalence of MDR isolates (>90%) were reported in two studies conducted in South Africa (Ateba and Bezuidenhout 2008; Iweriebor et al. 2015) . In both cases, elevated rates of resistance against sulphametoxazol and tetracycline were reported, but even more alarming was the detection of bla CTX-M and bla CMY genes encoding third-generation cephalosporin resistance (Iweriebor et al. 2015) . Healthy domestic ruminants, particularly cattle and sheep, are considered natural reservoirs of these pathogens, associated to clinical diseases such as diarrhoea, haemorrhagic colitis or haemolytic uraemic syndrome in humans. Thus, indirect selection of MDR isolates can contribute to an emergence of pathogenic strains posing a risk to public health.
ESBL, plasmid-mediated AMPc and carbapenemase-producing E. coli in husbandry animals
The first description of ESBL-producing E. coli from livestock origin in the African continent dates back to 2011 (Fortini et al. 2011) . Since then, many surveillance reports have been published, especially in northern Africa, reflecting an increased effort to understand the role of animals as reservoirs of ESBL and establish good control measures to avoid the spread of these bacteria.
Data from Table 1 , which collects all the published studies on ESBL-producing E. coli among African livestock and derived food, show that the prevalence of these resistant bacteria among healthy animals was highly variable depending on the study (from 0% to 42Á8%). This variability can be explained, in part, to differences in the methodology used. Of course, other factors like specific selective driving forces (antimicrobial usage), farming practices, geographical particularities, such as the predominance of specific clones, and even the studied animal breed (local/exotic) or age have demonstrated to affect the carriage percentages of ESBL among animals (Reist et al. 2013; Seni et al. 2016) . It is also important to mention that most of the surveys were carried out among poultry in comparison with other FPA species such as Letters in Applied Microbiology 64, 318--334 © 2017 The Society for Applied Microbiology cattle or pigs. Although the vast majority of analysed samples were faeces, one study conducted in Algeria (not considered in the previously given prevalence estimation because of the small number of samples included) reported the presence of ESBL-producing E. coli in the reproductive and gastrointestinal tract of nine broiler breeding roosters (Mezhoud et al. 2015) . Considering the few data available on diseased animal population (Table 2) , the number of studies among cattle and poultry is more homogeneous and mainly focused on chickens suffering from colibacillosis and cattle with clinical or subclinical mastitis. The prevalence of ESBL-producing E. coli among sick poultry varied from 0 to 24Á7% and for cattle was reported between 0 and 10% (although the number of studied E. coli strains was considerably lower in cattle).
Focusing on the diversity of ESBL enzymes among E. coli isolates from African livestock, those belonging to CTX-M-1 group have demonstrated to be more abundant than other ESBL groups or types (SHV or TEM ESBLs). In the majority of the surveys, bla CTX-M-15 was the most common ESBL gene detected with the exception of Tunisia, where many works reported CTX-M-1 as the main enzyme among poultry (Ben Sallem et al. 2012b; Mnif et al. 2012; Maamar et al. 2016) (Fig. 1a) . In Tunisia, CTX-M-1 has also been found as the most prevalent variant among ESBL-producing E. coli of healthy humans' intestinal microbiota (Ben Sallem et al. 2012a), whereas CTX-M-15 is the predominant enzyme among clinical ESBL-producer isolates (Dahmen et al. 2010; Ben Slama et al. 2011) . In fact, bla CTX-M-15 is in general the most frequently found ESBL gene among African hospital strains, regardless of the country (Storberg 2014) . In Algeria, a study carried out in slaughtered broilers showed a high prevalence of bla SHV-12 (Belmahdi et al. 2016) . However, most of the isolates carrying this bla gene were taken from chickens belonging to the same farm and showed equal sequence type, suggesting a possible spread of a specific clone in this farm more than a picture of the situation in the country. It is also remarkable the high rate of plasmid AmpC (pAmpC) b-lactamase, belonging in all cases to CMY-2 variant, identified among commensal E. coli from healthy chickens in Tunisia (Ben Sallem et al. 2012b; Mnif et al. 2012; Maamar et al. 2016) , Algeria (Belmahdi et al. 2016) and septicemic broilers in Egypt (Ahmed et al. 2013) . CMY-2, together with DHA-1, is the most frequently detected pAmpC variant among human clinical isolates in Africa (Storberg 2014) .
Considering carbapenemase production among E. coli isolates in the African continent, although many descriptions have been reported in humans (Robin et al. 2010; Moquet et al. 2011; Barguigua et al. 2013; Leski et al. 2013; Mushi et al. 2014 ) and the hospital environment (Chouchani et al. 2011 ) over the last 5 years, it has not been until very recently when the first carbapenemaseproducing E. coli was detected in pets (Yousfi et al. 2016) and livestock animals (Braun et al. 2016) . The previously described study, conducted in different dairy cattle farms from Egypt, reported four E. coli strains harbouring bla OXA-48 and one carrying bla OXA-181 carbapenemase genes, all of them phenotypically resistant to meropenem and imipenem. It is also important to mention the detection of an ertapenem-resistant ESBL-E. coli strain in a chicken from Nigeria. However, no carbapenemase was detected in this strain. The resistant phenotype was attributed to a synergistic effect between CTX-M-15 production and dysfunctionality of outer membrane protein (Ojo et al. 2016) .
Although CTX-M-15 was the predominant ESBL enzyme detected among livestock in many African countries such as Nigeria, Tanzania or Egypt, only in two surveillances this bla gene was shown to be associated with the human epidemic clone ST131. These ST131-CTX-M-15-producing E. coli isolates were identified in a healthy swine from Tanzania Seni et al. 2016) . Although phylogroup D has also been detected quite frequently among ESBL/AmpC producers from healthy poultry (Mnif et al. 2012) , phylogroup B2 was present at lower rates in all the studies considered in this review. Regarding publications on diseased animals, few of them provide a phylogenetic analysis of the ESBL isolates, making it difficult to generalize.
However, epidemiology of ESBL involves not only a clonal spread of bacteria but also the horizontal transfer of bla genes via plasmids and/or other transferable genetic structures. In this sense, although molecular information on mobile elements is scarce in Africa, there are some works that prove the importance of specific plasmids in (Grami et al. 2013 , Ojo et al. 2016 Seni et al. 2016) . In this regard, as it has been previously shown in other continents, the dominance of IncF-type plasmids carrying the bla CTX-M-15 gene among E. coli from human and animal origin has been also reported in Africa (Grami et al. 2014; Ojo et al. 2016; Seni et al. 2016) . But this emergent CTX-M-15 encoding gene has been also associated with other less common replicon plasmids such as IncY-type, which have shown to be very prevalent in animal isolates from Tanzania. Interestingly, in the same surveillance, the presence of an Inc-untypeable plasmid, co-harbouring bla CTX-M-15 and qnrS1 genes and genetically homologous to a previously described one from human origin in Nigeria, was detected in various animals. In Tunisia, where CTX-M-1 enzyme is broadly disseminated among poultry, two molecular studies confirmed its frequent association with IncI1/ST3 plasmids (Ben Sallem et al. 2014; Grami et al. 2013) . One of these surveys showed a comparison of clonal lineages and plasmids from healthy humans, animals and pets in Tunisia and demonstrated that bla CTX-M-1 -carrying IncI1/ST3 plasmids and bla CMY-2 -carrying IncI1/ST12 plasmids play a crucial role in the spread of these b-lactamases among different host and ecosystems (Ben Sallem et al. 2014) . Likewise, the other work concluded that examined bla CTX-M-1 -harbouring IncI1/ST3 plasmids of E. coli from Tunisian poultry and pets were identical or highly similar to those reported in various animal species in Europe (Dahmen et al. 2012) and in some humans infected with Salmonella enterica (Cloeckaert et al. 2010) , highlighting the international role of these mobile elements in CTX-M-1 epidemiology. In addition to plasmid promiscuity, the spread of CTX-M determinants is also favoured by flanking transposable elements, which can co-mobilize bla genes. This is the case of the ISEcp1 element, usually located immediately upstream bla CTX-M and bla CMY-2 genes. Occasionally, it appears truncated by other insertion sequences such as IS26 (Jouini et al. 2007 ), IS10 (Ben Sallem et al. 2012b) or IS5 (Maamar et al. 2016) , which could affect the mobilization and/or the expression of the b-lactamase gene (Lahlaoui et al. 2014; Maamar et al. 2016) .
ESBL, plasmid-mediated AMPc and carbapenemase-producing E. coli in animalderived food
There are a wide number of studies concerning the microbiological quality of different types of food derived from FPA (milk, cheese, meat, eggs, etc.) conducted in Africa. Most of them are focused on the detection of pathogenic bacteria (especially E. coli 0157) in order to determine the rate of contamination of the studied product (Bankole et al. 2014; Ombarak et al. 2016) or even to analyse the resistance and/or virulence patterns of bacteria present in milk collected from cattle suffering mastitis (Ahmed and Shimamoto 2011; Kateete et al. 2013) . However, there are just a few articles regarding the prevalence and characterization of ESBL/pAmpC E. coli among food products derived from healthy animals in different countries of the African continent. Remarkable data extracted from these reports is summarized in Table 1 . All the studies, but two which included different animal species (Jouini et al. 2007; Ben Slama et al. 2010) , were carried out on meat samples or swabs collected from poultry carcasses. This fact may be a reflection of the religious and cultural factors which influence the diet of people in many African countries. General prevalence of ESBL/pAmpC E. coli among meat products was an average of 16Á3%, although the risk of cross-contamination at the slaughterhouses should be considered. This percentage is significantly lower than those reported in many European countries such as Spain (84%-93Á3%) (Egea et al. 2012; Ojer-Usoz et al. 2013) or the Netherlands (76Á8%) (Overdevest et al. 2011) , which may indicate that resistance rates are higher in industrial large-scale meat production. Figure 1b shows the diversity of ESBL/pAmpC types detected among poultry (chicken and turkey), beef and sheep meat in different countries from Africa. Comparing with the distribution of enzymes detected among E. coli isolates from faecal poultry microbiota, a higher percentage of CTX-M-14 was identified among derived meat products. It is important to consider different factors that can help to understand these differences. First, it is difficult to elucidate the animal, human or environmental origin of the isolates due to the fact that contamination could take place at all the stages of the food-processing chain including processing, packing and distribution. Moreover, there are studies that demonstrate the contribution of imported meat from industrialized countries to the emergence of ESBL and multidrug-resistant isolates in developing countries (Schaumburg et al. 2014; Rasmussen et al. 2015) . One of these works, carried out in Ghana, showed significantly higher rates of ESBL/pAmpC E. coli in imported chicken meat (32Á9%) compared to locally reared chickens (13Á9%). CTX-M-15 was the most frequently detected ESBL variant. However, bla CTX-M-2 was also identified in two samples, one of them from an imported chicken thigh from Brazil, where this CTX-M enzyme is well known to be the most prevalent, together with CTX-M-15, among clinical isolates (Rocha et al. 2016 ). In the other study, conducted in Gabon, only imported frozen chicken meat samples were screened and a predominance of CTX-M-14, followed by CTX-M-1, was detected. Interestingly, all ESBL-producing E. coli isolates were identified in meat imported from Spain and, consequently, the distribution of ESBL types was shown to be in accordance to the proportion of CTX-M subtypes described in this country (Egea et al. 2012; Ojer-Usoz et al. 2013) .
Regarding studies on food from healthy animals, only two performed a molecular study of the clonal lineages associated with the spread of ESBLs (Jouini et al. 2013; Rasmussen et al. 2015) . Considering data from both reports, a high clonal diversity was observed, being slightly prevalent E. coli isolates belonging to ST155, ST10 and ST38. These sequence types have been previously identified in humans and livestock animals (Ben Sallem et al. 2012a; Day et al. 2016) , also associated to CTX-M-1 group ESBLs, suggesting a potential implication of the food chain in the spread of these resistant clones among different settings.
Although none of the studies performed in Africa have reported carbapenemase-producing E. coli isolates among food derived from livestock animals, it is important to highlight the detection of 12 NDM-producing Klebsiella isolates in retail chicken meat samples from Egypt (Abdallah et al. 2015) . Moreover, a recent study conducted in the same country has demonstrated a high rate of carbapenemase-producing Klebsiella pneumoniae strains, harbouring bla NDM , bla OXA-48 and/or bla KPC genes in broiler chickens (35%), drinking water (25%) and humans living in contact with chickens (56%) (Hamza et al. 2016) . Further studies based on multilocus sequence typing (MLST) or whole-genome sequencing should be performed to determine the potential inter-host transmission of these strains through direct contact and/or ingestion of derived contaminated meat.
Conclusions
The increasing rate of antimicrobial resistance bacteria is a global problem that affects both human and animal ecosystems. In the African region, the real magnitude of this issue is difficult to estimate due to the fact that antimicrobial resistance surveillance programmes are limited to a few countries (Ndihokubwayo et al. 2013) . The potential inter-host spread of resistant clones or even their encoding determinants through direct contact or ingestion of contaminated food pose a worrisome public health risk. Although in the last decade the number of surveys in Africa has increased, available information is still scarce in many countries, especially in Southern and Eastern Africa. Moreover, further
Letters in Applied Microbiology 64, 318--334 © 2017 The Society for Applied Microbiology molecular studies are required to characterize the prevailing clonal lineages and plasmids harbouring resistance encoding genes in this continent. The combination of factors such as the uncontrolled use of antimicrobials in livestock production, certain farming practices and manure management systems as well as close contact with animal may favour the selection of AMR bacteria and transmission from animals to humans and vice versa. Additionally, international livestock and derived meat trade is leading to an emergence in the dissemination of resistant strains and genetic determinants. Resistance to 'old' antimicrobials, such as tetracycline, penicillins or sulphonamides, which have been in use for a long time both in human and veterinary medicine is not surprising. However, in the last few years a significant increase in the prevalence of resistance to other clinically critical drugs (i.e. quinolones and third/fourth generation cephalosporins) has been reported among commensal E. coli from healthy livestock species. In most cases, resistance to both antimicrobial families is co-selected and disseminated not only by clonal spread but also horizontally via plasmids carrying qnr or aac(6)Ib-cr and bla genes (especially, of the CTX-M group). Furthermore, carbapenem-and colistin-resistant E. coli strains are also emerging among husbandry animals in Africa, which demonstrates the urgent need of a better control of the usage of veterinary drugs and the implementation of effective surveillance programmes to stop the dissemination of MDR E. coli strains.
